Literature DB >> 26403419

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.

Oriol Calvete1,2, Paula Martinez3, Pablo Garcia-Pavia4,5, Carlos Benitez-Buelga1, Beatriz Paumard-Hernández1, Victoria Fernandez1, Fernando Dominguez4, Clara Salas6, Nuria Romero-Laorden7, Jesus Garcia-Donas7, Jaime Carrillo8, Rosario Perona2,8, Juan Carlos Triviño9, Raquel Andrés10, Juana María Cano11, Bárbara Rivera12, Luis Alonso-Pulpon4, Fernando Setien13, Manel Esteller13,14,15, Sandra Rodriguez-Perales16, Gaelle Bougeard17, Tierry Frebourg17, Miguel Urioste2,12, Maria A Blasco3, Javier Benítez1,2.   

Abstract

Cardiac angiosarcoma (CAS) is a rare malignant tumour whose genetic basis is unknown. Here we show, by whole-exome sequencing of a TP53-negative Li-Fraumeni-like (LFL) family including CAS cases, that a missense variant (p.R117C) in POT1 (protection of telomeres 1) gene is responsible for CAS. The same gene alteration is found in two other LFL families with CAS, supporting the causal effect of the identified mutation. We extend the analysis to TP53-negative LFL families with no CAS and find the same mutation in a breast AS family. The mutation is recently found once in 121,324 studied alleles in ExAC server but it is not described in any other database or found in 1,520 Spanish controls. In silico structural analysis suggests how the mutation disrupts POT1 structure. Functional and in vitro studies demonstrate that carriers of the mutation show reduced telomere-bound POT1 levels, abnormally long telomeres and increased telomere fragility.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26403419      PMCID: PMC4598567          DOI: 10.1038/ncomms9383

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  42 in total

1.  ISIS: interaction sites identified from sequence.

Authors:  Yanay Ofran; Burkhard Rost
Journal:  Bioinformatics       Date:  2007-01-15       Impact factor: 6.937

2.  Familial cardiac angiosarcoma.

Authors:  Ingeborg M Keeling; Ferdinand Ploner; Bruno Rigler
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

3.  Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.

Authors:  Ming Lei; Elaine R Podell; Thomas R Cech
Journal:  Nat Struct Mol Biol       Date:  2004-11-21       Impact factor: 15.369

4.  Protein disorder prediction: implications for structural proteomics.

Authors:  Rune Linding; Lars Juhl Jensen; Francesca Diella; Peer Bork; Toby J Gibson; Robert B Russell
Journal:  Structure       Date:  2003-11       Impact factor: 5.006

5.  The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.

Authors:  Malak Abedalthagafi; Joanna J Phillips; Grace E Kim; Sabine Mueller; Daphne A Haas-Kogen; Roxanne E Marshall; Sidney E Croul; Mariarita R Santi; Jing Cheng; Shengmei Zhou; Lisa M Sullivan; Maria Martinez-Lage; Alexander R Judkins; Arie Perry
Journal:  Mod Pathol       Date:  2013-06-14       Impact factor: 7.842

Review 6.  Pot1 and telomere maintenance.

Authors:  Peter Baumann; Carolyn Price
Journal:  FEBS Lett       Date:  2010-05-21       Impact factor: 4.124

7.  POT1 loss-of-function variants predispose to familial melanoma.

Authors:  Carla Daniela Robles-Espinoza; Mark Harland; Andrew J Ramsay; Lauren G Aoude; Víctor Quesada; Zhihao Ding; Karen A Pooley; Antonia L Pritchard; Jessamy C Tiffen; Mia Petljak; Jane M Palmer; Judith Symmons; Peter Johansson; Mitchell S Stark; Michael G Gartside; Helen Snowden; Grant W Montgomery; Nicholas G Martin; Jimmy Z Liu; Jiyeon Choi; Matthew Makowski; Kevin M Brown; Alison M Dunning; Thomas M Keane; Carlos López-Otín; Nelleke A Gruis; Nicholas K Hayward; D Timothy Bishop; Julia A Newton-Bishop; David J Adams
Journal:  Nat Genet       Date:  2014-03-30       Impact factor: 38.330

8.  Large-scale genotyping identifies 41 new loci associated with breast cancer risk.

Authors:  Kyriaki Michailidou; Per Hall; Anna Gonzalez-Neira; Maya Ghoussaini; Joe Dennis; Roger L Milne; Marjanka K Schmidt; Jenny Chang-Claude; Stig E Bojesen; Manjeet K Bolla; Qin Wang; Ed Dicks; Andrew Lee; Clare Turnbull; Nazneen Rahman; Olivia Fletcher; Julian Peto; Lorna Gibson; Isabel Dos Santos Silva; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Kamila Czene; Astrid Irwanto; Jianjun Liu; Quinten Waisfisz; Hanne Meijers-Heijboer; Muriel Adank; Rob B van der Luijt; Rebecca Hein; Norbert Dahmen; Lars Beckman; Alfons Meindl; Rita K Schmutzler; Bertram Müller-Myhsok; Peter Lichtner; John L Hopper; Melissa C Southey; Enes Makalic; Daniel F Schmidt; Andre G Uitterlinden; Albert Hofman; David J Hunter; Stephen J Chanock; Daniel Vincent; François Bacot; Daniel C Tessier; Sander Canisius; Lodewyk F A Wessels; Christopher A Haiman; Mitul Shah; Robert Luben; Judith Brown; Craig Luccarini; Nils Schoof; Keith Humphreys; Jingmei Li; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Fergus J Couch; Xianshu Wang; Celine Vachon; Kristen N Stevens; Diether Lambrechts; Matthieu Moisse; Robert Paridaens; Marie-Rose Christiaens; Anja Rudolph; Stefan Nickels; Dieter Flesch-Janys; Nichola Johnson; Zoe Aitken; Kirsimari Aaltonen; Tuomas Heikkinen; Annegien Broeks; Laura J Van't Veer; C Ellen van der Schoot; Pascal Guénel; Thérèse Truong; Pierre Laurent-Puig; Florence Menegaux; Frederik Marme; Andreas Schneeweiss; Christof Sohn; Barbara Burwinkel; M Pilar Zamora; Jose Ignacio Arias Perez; Guillermo Pita; M Rosario Alonso; Angela Cox; Ian W Brock; Simon S Cross; Malcolm W R Reed; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Irene L Andrulis; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Annika Lindblom; Sara Margolin; Maartje J Hooning; Antoinette Hollestelle; Ans M W van den Ouweland; Agnes Jager; Quang M Bui; Jennifer Stone; Gillian S Dite; Carmel Apicella; Helen Tsimiklis; Graham G Giles; Gianluca Severi; Laura Baglietto; Peter A Fasching; Lothar Haeberle; Arif B Ekici; Matthias W Beckmann; Hermann Brenner; Heiko Müller; Volker Arndt; Christa Stegmaier; Anthony Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Jonine Figueroa; Jolanta Lissowska; Louise Brinton; Mark S Goldberg; France Labrèche; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Hiltrud Brauch; Ute Hamann; Thomas Brüning; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Bernardo Bonanni; Peter Devilee; Rob A E M Tollenaar; Caroline Seynaeve; Christi J van Asperen; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Natalia V Bogdanova; Natalia N Antonenkova; Thilo Dörk; Vessela N Kristensen; Hoda Anton-Culver; Susan Slager; Amanda E Toland; Stephen Edge; Florentia Fostira; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Keitaro Matsuo; Hidemi Ito; Hiroji Iwata; Aiko Sueta; Anna H Wu; Chiu-Chen Tseng; David Van Den Berg; Daniel O Stram; Xiao-Ou Shu; Wei Lu; Yu-Tang Gao; Hui Cai; Soo Hwang Teo; Cheng Har Yip; Sze Yee Phuah; Belinda K Cornes; Mikael Hartman; Hui Miao; Wei Yen Lim; Jen-Hwei Sng; Kenneth Muir; Artitaya Lophatananon; Sarah Stewart-Brown; Pornthep Siriwanarangsan; Chen-Yang Shen; Chia-Ni Hsiung; Pei-Ei Wu; Shian-Ling Ding; Suleeporn Sangrajrang; Valerie Gaborieau; Paul Brennan; James McKay; William J Blot; Lisa B Signorello; Qiuyin Cai; Wei Zheng; Sandra Deming-Halverson; Martha Shrubsole; Jirong Long; Jacques Simard; Montse Garcia-Closas; Paul D P Pharoah; Georgia Chenevix-Trench; Alison M Dunning; Javier Benitez; Douglas F Easton
Journal:  Nat Genet       Date:  2013-04       Impact factor: 38.330

9.  RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses.

Authors:  Miriam Rubio-Camarillo; Gonzalo Gómez-López; José M Fernández; Alfonso Valencia; David G Pisano
Journal:  Bioinformatics       Date:  2013-04-28       Impact factor: 6.937

10.  Germline mutations in shelterin complex genes are associated with familial glioma.

Authors:  Matthew N Bainbridge; Georgina N Armstrong; M Monica Gramatges; Alison A Bertuch; Shalini N Jhangiani; Harsha Doddapaneni; Lora Lewis; Joseph Tombrello; Spyros Tsavachidis; Yanhong Liu; Ali Jalali; Sharon E Plon; Ching C Lau; Donald W Parsons; Elizabeth B Claus; Jill Barnholtz-Sloan; Dora Il'yasova; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Daniel Lachance; Sara H Olson; Jonine L Bernstein; Ryan T Merrell; Margaret R Wrensch; Kyle M Walsh; Faith G Davis; Rose Lai; Sanjay Shete; Kenneth Aldape; Christopher I Amos; Patricia A Thompson; Donna M Muzny; Richard A Gibbs; Beatrice S Melin; Melissa L Bondy
Journal:  J Natl Cancer Inst       Date:  2014-12-07       Impact factor: 11.816

View more
  63 in total

Review 1.  Stop pulling my strings - what telomeres taught us about the DNA damage response.

Authors:  Eros Lazzerini-Denchi; Agnel Sfeir
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-11       Impact factor: 94.444

2.  Critical role of the POT1 OB domain in maintaining genomic stability.

Authors:  T K Pandita
Journal:  Oncogene       Date:  2016-11-21       Impact factor: 9.867

3.  A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.

Authors:  Huiling He; Wei Li; Daniel F Comiskey; Sandya Liyanarachchi; Taina T Nieminen; Yanqiang Wang; Katherine E DeLap; Pamela Brock; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-02       Impact factor: 6.568

4.  Molecular Architecture of Full-length TRF1 Favors Its Interaction with DNA.

Authors:  Jasminka Boskovic; Jaime Martinez-Gago; Marinela Mendez-Pertuz; Alberto Buscato; Jorge Luis Martinez-Torrecuadrada; Maria A Blasco
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

5.  Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.

Authors:  Aida Orois; Celia Badenas; Jordi L Reverter; Verónica López; Miriam Potrony; Mireia Mora; Irene Halperin; Josep Oriola
Journal:  Horm Cancer       Date:  2020-03-14       Impact factor: 3.869

6.  Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.

Authors:  Matthew Breen; Jaime F Modiano; Ingegerd Elvers; Kerstin Lindblad-Toh; Kate Megquier; Jason Turner-Maier; Ross Swofford; Jong-Hyuk Kim; Aaron L Sarver; Chao Wang; Sharadha Sakthikumar; Jeremy Johnson; Michele Koltookian; Mitzi Lewellen; Milcah C Scott; Ashley J Schulte; Luke Borst; Noriko Tonomura; Jessica Alfoldi; Corrie Painter; Rachael Thomas; Elinor K Karlsson
Journal:  Mol Cancer Res       Date:  2019-09-30       Impact factor: 5.852

7.  POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families.

Authors:  Erica Shen; Joanne Xiu; Giselle Y Lopez; Rex Bentley; Ali Jalali; Amy B Heimberger; Matthew N Bainbridge; Melissa L Bondy; Kyle M Walsh
Journal:  J Med Genet       Date:  2020-01-14       Impact factor: 6.318

Review 8.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

9.  POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

Authors:  M Potrony; J A Puig-Butille; M Ribera-Sola; V Iyer; C D Robles-Espinoza; P Aguilera; C Carrera; J Malvehy; C Badenas; M T Landi; D J Adams; S Puig
Journal:  Br J Dermatol       Date:  2019-02-27       Impact factor: 9.302

Review 10.  The shelterin complex and hematopoiesis.

Authors:  Morgan Jones; Kamlesh Bisht; Sharon A Savage; Jayakrishnan Nandakumar; Catherine E Keegan; Ivan Maillard
Journal:  J Clin Invest       Date:  2016-05-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.